Maryland State Retirement & Pension System’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Maryland State Retirement & Pension System’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,254	Closed	-$250K	–	1573
2023 Q4	$250K	Buy	+4,254	New	+$239K	0.01%	1469
2022 Q2	–	Sell	-2,904	Closed	-$239K	–	1546
2022 Q1	$239K	Hold	2,904	–	–	0.01%	1417
2021 Q4	$426K	Buy	2,904 +182	+7%	+$28.3K	0.01%	1181
2021 Q3	$483K	Hold	2,722	–	–	0.01%	1104
2021 Q2	$446K	Buy	+2,722	New	+$437K	0.01%	762

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Maryland State Retirement & Pension System's MRTX Position: Q1 2024 in Review

Maryland State Retirement & Pension System sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 4,254 shares — an estimated $250K sold.

Maryland State Retirement & Pension System first reported a position in MRTX in Q2 2021 and held it in 5 quarters. The position peaked at $483K in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Maryland State Retirement & Pension System reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Maryland State Retirement & Pension System sold 4,254 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $250K.
Maryland State Retirement & Pension System first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Maryland State Retirement & Pension System's Mirati Therapeutics, Inc. Common Stock position peaked at $483K in Q3 2021.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2024, filed 19 Apr 2024.